Amputation for Circulatory System Disorders DRG 240

DRG 240 addresses inpatient admissions for lower extremity amputation due to circulatory system disorders with a Complication or Comorbidity, encompassing procedures more complex than simple toe or upper limb amputations. This Diagnosis-Related Group matters for inpatient reimbursement because it reflects increased resource utilization and influences Medicare payment rates tied to case complexity.

DRG 240 Overview

DRG 240 covers inpatient admissions for lower extremity amputation procedures performed for circulatory system disorders, excluding upper limb and toe, when a Complication or Comorbidity is present. This Diagnosis-Related Group groups patients by clinical similarity and resource use to determine Medicare inpatient reimbursement. Cases in this DRG typically reflect significant vascular disease requiring surgical removal of part of a lower extremity and have increased complexity when a Complication or Comorbidity is coded. Accurate coding and documentation of the amputation level and associated Complication or Comorbidity are important for correct Medicare Severity Diagnosis-Related Group assignment and payment.

Acute perioperative optimization studies: randomized or pragmatic trials testing protocols to reduce perioperative morbidity and mortality for patients undergoing major lower-extremity amputations due to ischemic or infectious circulatory disease. These studies enroll elderly patients with peripheral arterial disease, diabetes-related limb ischemia, or critical limb-threatening ischemia who require transfemoral, transtibial, or other non-upper-limb amputations, and compare approaches such as standardized hemodynamic optimization, infection control bundles, and multimodal analgesia pathways. Results inform surgeons, hospitalists, and payers about interventions that can shorten length of stay, reduce ICU utilization, and lower complication-related costs during the index admission.
Comparative effectiveness and limb-salvage timing studies: observational cohort studies and randomized trials comparing early revascularization attempts (endovascular or open) versus primary amputation, or comparing different timing strategies for amputation after failed revascularization in patients with severe peripheral arterial disease and tissue loss. These studies focus on functional outcomes, reoperation rates, wound healing, and resource use among patients with limb-threatening ischemia, many of whom have comorbid diabetes, renal disease, or infection-related complications. Findings are relevant to clinicians and payers for determining cost-effective care pathways that balance attempts at limb salvage against risks of prolonged hospitalization, multiple procedures, and readmissions.
Post-discharge rehabilitation, prosthetic integration, and readmission reduction trials: prospective studies and implementation research testing inpatient-to-outpatient transitional care models, tailored rehabilitation programs, and prosthesis fitting timelines to improve mobility, reduce pressure wound recurrence, and prevent readmissions for patients after lower-extremity amputation for circulatory system disorders. Typical study populations include older adults with multiple comorbidities discharged to home or skilled nursing facilities, and outcomes include functional independence, quality of life, wound complications, and healthcare utilization in the 30–365 day post-discharge period. These trials inform discharge planning, bundled payment models, and payer decisions around coverage of rehabilitation and home health services to decrease long-term costs and improve patient-centered outcomes.

Acute perioperative optimization studies: randomized or pragmatic trials testing protocols to reduce perioperative morbidity and mortality for patients undergoing major lower-extremity amputations due to ischemic or infectious circulatory disease. These studies enroll elderly patients with peripheral arterial disease, diabetes-related limb ischemia, or critical limb-threatening ischemia who require transfemoral, transtibial, or other non-upper-limb amputations, and compare approaches such as standardized hemodynamic optimization, infection control bundles, and multimodal analgesia pathways. Results inform surgeons, hospitalists, and payers about interventions that can shorten length of stay, reduce ICU utilization, and lower complication-related costs during the index admission.
Comparative effectiveness and limb-salvage timing studies: observational cohort studies and randomized trials comparing early revascularization attempts (endovascular or open) versus primary amputation, or comparing different timing strategies for amputation after failed revascularization in patients with severe peripheral arterial disease and tissue loss. These studies focus on functional outcomes, reoperation rates, wound healing, and resource use among patients with limb-threatening ischemia, many of whom have comorbid diabetes, renal disease, or infection-related complications. Findings are relevant to clinicians and payers for determining cost-effective care pathways that balance attempts at limb salvage against risks of prolonged hospitalization, multiple procedures, and readmissions.
Post-discharge rehabilitation, prosthetic integration, and readmission reduction trials: prospective studies and implementation research testing inpatient-to-outpatient transitional care models, tailored rehabilitation programs, and prosthesis fitting timelines to improve mobility, reduce pressure wound recurrence, and prevent readmissions for patients after lower-extremity amputation for circulatory system disorders. Typical study populations include older adults with multiple comorbidities discharged to home or skilled nursing facilities, and outcomes include functional independence, quality of life, wound complications, and healthcare utilization in the 30–365 day post-discharge period. These trials inform discharge planning, bundled payment models, and payer decisions around coverage of rehabilitation and home health services to decrease long-term costs and improve patient-centered outcomes.

OpenPayer

Summary & Overview

Amputation for Circulatory System Disorders Except Upper Limb and Toe with CC: Inpatient Reimbursement Overview

DRG 240 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes